Glenmark Pharmaceuticals

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue6,2483,9453,9604,0844,250
Expenses3,8953,2273,1993,4413,628
EBITDA2,560914.22951.68870.56866.35
EBIT1,034575.43430.37697.39402.06
Profit Before Tax967.40534.00387.77643.39338.29
Net Profit610.43403.23301.32482.83263.83
Financial Ratios
Operating Profit Margin19.57%18.77%15.38%22.14%14.01%
Net Profit Margin25.57%13.89%14.96%12.28%10.59%
Earning Per Share (Diluted)21.6214.2810.6817.119.34
Dividends Per Share0.000.000.000.000.00